{
    "startDate": "2017-01-01",
    "endDate": "2017-12-31",
    "year": "2017",
    "quarter": "FY",
    "symbol": "SPPI",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 227323000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 248000
            },
            {
                "label": "Accounts receivable, net of allowance for doubtful accounts of $71 and $88, respectively",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 32260000
            },
            {
                "label": "Other receivables",
                "concept": "OtherReceivables",
                "unit": "usd",
                "value": 2133000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 5715000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 10067000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 277746000
            },
            {
                "label": "Property and equipment, net of accumulated depreciation",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 589000
            },
            {
                "label": "Intangible assets, net of accumulated amortization and impairment charges",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 137159000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 18162000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 53783000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 487439000
            },
            {
                "label": "Accounts payable and other accrued liabilities",
                "concept": "AccountsPayableAndOtherAccruedLiabilities",
                "unit": "usd",
                "value": 58117000
            },
            {
                "label": "Accrued payroll and benefits",
                "concept": "AccruedEmployeeBenefitsCurrent",
                "unit": "usd",
                "value": 9261000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 3872000
            },
            {
                "label": "FOLOTYN development liability",
                "concept": "sppi:AccruedDrugDevelopmentCosts",
                "unit": "usd",
                "value": 275000
            },
            {
                "label": "Convertible senior notes",
                "concept": "SeniorNotesCurrent",
                "unit": "usd",
                "value": 38224000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 109749000
            },
            {
                "label": "FOLOTYN development liability, less current portion",
                "concept": "sppi:AccruedDrugDevelopmentCostsNoncurrent",
                "unit": "usd",
                "value": 12111000
            },
            {
                "label": "Deferred revenue, less current portion",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 315000
            },
            {
                "label": "Acquisition-related contingent obligations",
                "concept": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
                "unit": "usd",
                "value": 6272000
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 1438000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "sppi:ContingentObligationsRelatedToAcquisition",
                "unit": "usd",
                "value": 6215000
            },
            {
                "label": "Convertible senior notes",
                "concept": "SeniorLongTermNotes",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 136100000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, $0.001 par value; 175,000,000 shares authorized; 100,742,735 and 80,466,735 issued and outstanding at December 31, 2017 and 2016, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 837347000
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 15999000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -502107000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 351339000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 487439000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -91248000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 27972000
            },
            {
                "label": "Equity Award [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 15139000
            },
            {
                "label": "Accretion of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 4890000
            },
            {
                "label": "Amortization of deferred financing costs, recorded to interest expense on 2018 Convertible Notes (Note 15)",
                "concept": "WriteOffOfDeferredDebtIssuanceCost",
                "unit": "usd",
                "value": 567000
            },
            {
                "label": "Bad debt (recovery) expense",
                "concept": "ProvisionForDoubtfulAccounts",
                "unit": "usd",
                "value": -17000
            },
            {
                "label": "Unrealized foreign currency exchange gain",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Loss on 2018 Convertible Note purchase (Note 15)",
                "concept": "sppi:GainLossOnRepurchaseOfNote",
                "unit": "usd",
                "value": -845000
            },
            {
                "label": "Change in cash surrender value of corporate owned life insurance",
                "concept": "LifeInsuranceCorporateOrBankOwnedChangeInValue",
                "unit": "usd",
                "value": 418000
            },
            {
                "label": "Income tax recognition on unrealized gain on available-for-sale securities",
                "concept": "AvailableforsaleSecuritiesGrossUnrealizedGainLoss1",
                "unit": "usd",
                "value": 9651000
            },
            {
                "label": "Impairment of intangible assets (Note 3(g))",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in fair value of contingent consideration related to the Talon and EVOMELA acquisitions (Note 10)",
                "concept": "sppi:ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue",
                "unit": "usd",
                "value": -4957000
            },
            {
                "label": "Research and development expense",
                "concept": "OtherResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -7694000
            },
            {
                "label": "Other receivables",
                "concept": "IncreaseDecreaseInOtherReceivables",
                "unit": "usd",
                "value": -3663000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": -4318000
            },
            {
                "label": "Prepaid expenses",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 6137000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -1573000
            },
            {
                "label": "Accounts payable and other accrued obligations",
                "concept": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 5518000
            },
            {
                "label": "Accrued payroll and benefits",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 280000
            },
            {
                "label": "FOLOTYN development liability",
                "concept": "sppi:IncreaseDecreaseInAccruedDrugDevelopmentCosts",
                "unit": "usd",
                "value": -744000
            },
            {
                "label": "Acquisition-related contingent obligations",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 593000
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "sppi:IncreaseDecreaseInDeferredTaxLiabilities",
                "unit": "usd",
                "value": -5237000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "sppi:IncreaseDecreaseInOtherLongTermLiabilities",
                "unit": "usd",
                "value": -3389000
            },
            {
                "label": "Cash Flows From Operating Activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -38855000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 465000
            },
            {
                "label": "Payment for corporate-owned life insurance premiums",
                "concept": "PaymentsToAcquireLifeInsurancePolicies",
                "unit": "usd",
                "value": 601000
            },
            {
                "label": "Purchase of equity securities (Note 11)",
                "concept": "PaymentsToAcquireInvestments",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Proceeds from sale of available-for-sale securities",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash Flows From Investing Activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -1081000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 5477000
            },
            {
                "label": "Proceeds from sale of stock under employee stock purchase plan",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": 1010000
            },
            {
                "label": "Purchase and retirement of restricted stock to satisfy employees' tax liability at vesting",
                "concept": "sppi:RepurchaseOfSharesToSatisfyMinimumTaxWithholdingForRestrictedStockVesting",
                "unit": "usd",
                "value": 4331000
            },
            {
                "label": "Payment of contingent consideration related to EVOMELA acquisition (Note 10(b))",
                "concept": "PaymentsForPreviousAcquisition",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from common shares sold under an at-market-issuance sales agreement (Note 7)",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 128272000
            },
            {
                "label": "Purchase of 2018 Convertible Notes (Note 15)",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": 27500000
            },
            {
                "label": "Purchase of warrants related to the conversion hedge of 2018 Convertible Notes (Note 15)",
                "concept": "PaymentsForRepurchaseOfWarrants",
                "unit": "usd",
                "value": 27189000
            },
            {
                "label": "Proceeds from sale of call options related to the conversion hedge of 2018 Convertible Notes (Note 15)",
                "concept": "ProceedsFromHedgeFinancingActivities",
                "unit": "usd",
                "value": 32982000
            },
            {
                "label": "Dividends paid upon conversion of Series E Convertible Voting Preferred Stock (Note 7)",
                "concept": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash Flows From Financing Activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 108721000
            },
            {
                "label": "Effect of exchange rates on cash and equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations",
                "unit": "usd",
                "value": 316000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 69101000
            },
            {
                "label": "Cash paid for income taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 17000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 2692000
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -91248000
            },
            {
                "label": "Unrealized gain (loss) on available-for-sale securities, net of income tax expense of $9.7 million, $2.2 million, and $0 for the years ended December 31, 2017, 2016, and 2015, respectively (see Note 3(h))",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 16039000
            },
            {
                "label": "Foreign currency translation adjustments",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 1539000
            },
            {
                "label": "Other comprehensive income (loss), net",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 17578000
            },
            {
                "label": "Total comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -73670000
            },
            {
                "label": "Product sales, net",
                "concept": "SalesRevenueGoodsNet",
                "unit": "usd",
                "value": 116178000
            },
            {
                "label": "License fees and service revenue",
                "concept": "SalesRevenueServicesNet",
                "unit": "usd",
                "value": 12189000
            },
            {
                "label": "Total revenues",
                "concept": "SalesRevenueNet",
                "unit": "usd",
                "value": 128367000
            },
            {
                "label": "Cost of sales (excludes amortization and impairment charges of intangible assets)",
                "concept": "sppi:CostOfSalesExcludingAmortizationExpense",
                "unit": "usd",
                "value": 42859000
            },
            {
                "label": "Cost of service revenue",
                "concept": "CostOfServices",
                "unit": "usd",
                "value": 4359000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 84267000
            },
            {
                "label": "Research and Development Costs",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 65895000
            },
            {
                "label": "Amortization and impairment charges of intangible assets",
                "concept": "CostOfGoodsSoldAmortization",
                "unit": "usd",
                "value": 27647000
            },
            {
                "label": "Total operating costs and expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 225027000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -96660000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": -6798000
            },
            {
                "label": "Change in fair value of contingent consideration related to the Talon and EVOMELA acquisitions (Note 10)",
                "concept": "sppi:ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue",
                "unit": "usd",
                "value": -4957000
            },
            {
                "label": "Other (expense) income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 389000
            },
            {
                "label": "Other (expense) income:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -11366000
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -108026000
            },
            {
                "label": "Benefit (provision) for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -16778000
            },
            {
                "label": "Net loss per share, basic and diluted ($ per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -1.07
            },
            {
                "label": "Diluted ($ per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -1.07
            },
            {
                "label": "Basic (shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 85115592
            },
            {
                "label": "Diluted (shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 85115592
            }
        ]
    }
}